Fig. 1From: Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database studyStudy design and screening criteria flow chart for the inclusion of T2DM patients with SGLT2i as first-line treatment and metformin as first-line treatmentBack to article page